Latest News

Newly identified antibodies effectively treat Alzheimer's-like disease in mice

Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can prevent the accumulation of one of these of these toxic components, called tau proteins. The findings suggest that these antibodies may provide a basis for a promising therapy for patients with Alzheimer's disease and other neurodegenerative disorders.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • A bad buzz: Men with HIV need fewer drinks to feel effects

  • Listen to your heart: Why your brain may give away how well you know yourself

  • Mindfulness-based therapy could offer an alternative to antidepressants for preventing depression relapse

  • New guideline advises when to treat a first seizure

  • Extending natalizumab up to 8 weeks shown safe and effective in patients with multiple sclerosis, report says

  • PTSD common in ICU Survivors

  • Frequent indoor tanning among teens shows correlation with smoking, social media use

  • Autism-epilepsy connection explored in four studies

  • Video games in care homes: connecting older adults, or exposing age-related vulnerability?

  • Reducing global tobacco use

  •